Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="LASTOWSKA, M" or (type exact bookEditor and editor="LASTOWSKA, M")

Add to list
- Journal Article
- A1
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

Jo Vandesompele (UGent) , M BAUDIS, Katleen De Preter (UGent) , Nadine Van Roy (UGent) , P AMBROS, N BOWN, C BRINKSCHMIDT, H CHRISTIANSEN, V COMBARET, M LASTOWSKA, et al.

(2005) JOURNAL OF CLINICAL ONCOLOGY. 23(10). p.2280-2299
Add to list
- Journal Article
- A1
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.

M LASTOWSKA, Nadine Van Roy (UGent) , N BOWN, Franki Speleman (UGent) , P ROBERTS, J LUNEC, T STRACHAN, ADJ PEARSON and MS JACKSON

(2001) MEDICAL AND PEDIATRIC ONCOLOGY. 36(1). p.20-23
Add to list
- Journal Article
- A1
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?

Jo Vandesompele (UGent) , Franki Speleman (UGent) , Nadine Van Roy (UGent) , Genevieve Laureys (UGent) , C BRINKSCHMIDT, H CHRISTIANSEN, F LAMPERT, M LASTOWSKA, N BOWN, A PEARSON, et al.

(2001) MEDICAL AND PEDIATRIC ONCOLOGY. 36(1). p.5-10
Add to list
- Journal Article
- A2
Deletion of chromosome 11q is the most frequent deletion detected by CGH in metastatic neuroblastoma lacking MYCN amplification

D PLANTAZ, J VANDESOMPELE, Nadine Van Roy (UGent) , N BROWN, J NICHOLSON, M LASTOWSKA, A PEARSON, C BRINKSCHMIDT, H CHRISTIANSEN, F LAMPERT, et al.

(2001) Int. J. of Cancer. 91. p.680-686
Add to list
- Journal Article
- A1
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification.

D PLANTAZ, Jo Vandesompele (UGent) , Nadine Van Roy (UGent) , M LASTOWSKA, N BOWN, V COMBARET, MC FAVROT, O DELATTRE, J MICHON, J BENARD, et al.

(2001) INTERNATIONAL JOURNAL OF CANCER. 91(5). p.680-686
Add to list
- Journal Article
- A1
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.

N BOWN, S COTTERILL, M LASTOWSKA, S O'NEILL, ADJ PEARSON, D PLANTAZ, M MEDDEB, G DANGLOT, C BRINKSCHMIDT, H CHRISTIANSEN, et al.

(1999) NEW ENGLAND JOURNAL OF MEDICINE. 340(25). p.1954-1961
Add to list
- Journal Article
- A1
Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.

M LASTOWSKA, Nadine Van Roy (UGent) , N BROWN, Franki Speleman (UGent) , J LUNEC, T STRACHAN, ADJ PEARSON and MS JACKSON

(1998) GENES CHROMOSOMES & CANCER. 23(2). p.116-122

Academic Bibliography

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma

Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.

Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?

Deletion of chromosome 11q is the most frequent deletion detected by CGH in metastatic neuroblastoma lacking MYCN amplification

Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification.

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.

Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.

Contents

Support

Contact